LIFEVANTAGE CORP Additional Paid in Capital, Common Stock
LIFEVANTAGE CORP (LFVN) had Additional Paid in Capital, Common Stock of $138.92 million as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-27
- 2026-06-30: Additional Paid in Capital, Common Stock $138.92M.
- 2026-03-31: Additional Paid in Capital, Common Stock $138.73M.
- 2025-12-31: Additional Paid in Capital, Common Stock $138.04M.
- 2025-09-30: Additional Paid in Capital, Common Stock $137.65M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $138.92M 10-K · filed 2026-08-27 | |
| 2026-03-31 | $138.73M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $138.04M 10-Q · filed 2026-02-04 | |
| 2025-09-30 | $137.65M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $139.96M 10-K · filed 2026-08-27 | |
| 2025-03-31 | $139.07M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $138.17M 10-Q · filed 2025-02-05 | |
| 2024-09-30 | $137.35M 10-Q · filed 2024-10-29 | |
| 2024-06-30 | $136.64M 10-K · filed 2025-09-04 | |
| 2024-03-31 | $136.20M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $135.49M 10-Q · filed 2024-01-30 | |
| 2023-09-30 | $134.95M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $134.31M 10-K · filed 2024-08-28 | |
| 2023-03-31 | $133.42M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $132.53M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $131.73M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $131.07M 10-K · filed 2023-08-28 | |
| 2022-03-31 | $130.71M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $130.59M 10-Q · filed 2022-02-01 | |
| 2021-09-30 | $129.86M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $129.05M 10-K · filed 2022-08-23 | |
| 2021-03-31 | $128.84M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $128.01M 10-Q · filed 2021-02-02 | |
| 2020-09-30 | $126.69M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $126.42M 10-K · filed 2021-08-19 | |
| 2020-03-31 | $125.70M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $125.86M 10-Q · filed 2020-01-28 | |
| 2019-09-30 | $128.66M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $127.10M 10-K · filed 2020-08-18 | |
| 2019-03-31 | $125.69M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $123.50M 10-Q · filed 2019-02-04 | |
| 2018-09-30 | $125.46M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $124.66M 10-K · filed 2019-08-14 | |
| 2018-03-31 | $123.95M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $122.63M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $122.01M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $121.60M 10-K · filed 2018-08-15 | |
| 2017-03-31 | $120.46M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $121.17M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $120.83M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $119.24M 10-K · filed 2017-09-07 | $120.15M 10-K · filed 2016-12-12 |
| 2016-03-31 | $119.37M 10-Q/A · filed 2016-07-19 | |
| 2015-12-31 | $118.65M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $117.83M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $117.66M 10-K · filed 2016-12-12 | $117.57M 10-K · filed 2015-09-01 |
| 2015-03-31 | $117.25M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $116.30M 10-Q · filed 2015-02-04 | |
| 2014-09-30 | $115.68M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $115.24M 10-K · filed 2015-09-01 | |
| 2014-03-31 | $113.69M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $113.01M 10-Q · filed 2014-02-06 | |
| 2013-09-30 | $111.43M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $110.41M 10-K · filed 2014-09-10 | |
| 2013-03-31 | $108.85M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $107.70M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $106.83M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $105.15M 10-K · filed 2013-09-12 | $105.15M 10-K · filed 2012-09-10 |
| 2012-03-31 | $104.26M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $85.82M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $68.40M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $67.61M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |